Skip to Content

UK Edition. Click here for US version.


Active substance(s): AMIKACIN SULPHATE

PDF options:  View Fullscreen   Download PDF

PDF Transcript

Amikacin 250 mg/ml Injection
Read all of this leaflet carefully before you start using
this medicine.
• Keep this leaflet. You may need to read it again.
• If you have any further questions, ask your doctor or
• If any of the side effects gets serious, or if you notice any
side effects not listed in this leaflet, please tell your doctor.
In this leaflet:
1. What Amikacin Injection is and what it is used for
2. Before you use Amikacin Injection
3. How to use Amikacin Injection
4. Possible side effects
5. How to store Amikacin Injection
6. Further information

Amikacin Injection is one of a group of antibiotic medicines called
Amikacin Injection is used in the treatment of serious infections
caused by bacteria sensitive to amikacin.

Do not use Amikacin Injection
• if you have shown signs of hypersensitivity (severe allergy) to
amikacin, or any of the other ingredients listed in section 6, in
the past
• if you suffer from a disorder called myasthenia gravis (severe
weakness of certain muscles of the body)
Tell your doctor if any of the above applies to you before this
medicine is used.

Take special care with Amikacin Injection
• if you have kidney problems
• if you have hearing difficulties or tinnitus (ringing or buzzing in
the ears)
• if you have shown signs of allergy to any of the antibiotics
related to amikacin (aminoglycosides) in the past
• If you have a known allergy to sulphites
Amikacin should be used with caution in premature and neonatal
Tell your doctor if any of the above applies to you before this
medicine is used.

Taking/using other medicines
Special care is needed if you are taking/using other medicines, as
some could interact with amikacin for example:
• diuretics (water tablets) such as furosemide and ethacrynic acid
• other antibiotics that can affect your kidneys, hearing or balance
• anaesthetics or muscle-relaxing drugs
• indomethacin (an anti-inflammatory medicine)
• other antibiotics called beta-lactamases such as penicillins or
• bisphosphonates; drugs used to treat loss of bone mass
• vitamin B1 (thiamine)
• platinum compounds used in chemotherapy such as cisplatin
Please tell your doctor if you are taking or have recently taken
any other medicines, including medicines obtained without a

Pregnancy and breast-feeding
Tell your doctor if you are pregnant, trying to become pregnant
or breast-feeding. Your doctor will only use this medicine if the
expected benefits outweigh any potential risk to your baby.
Ask your doctor or pharmacist for advice before taking any

Driving and using machines
Do not drive or use machines if you experience any side
effect (e.g. dizziness) which may lessen your ability to do so.

Important information about some of the ingredients of
Amikacin Injection
This medicine contains sodium metabisulphite, which may
rarely cause hypersensitivity (severe allergy) reactions and
bronchospasm (breathing difficulties).
This medicinal product contains less than 1 mmol (23 mg) sodium
per dose, i.e. essentially ‘sodium free’.

This medicine is usually injected into a muscle. It may also be
given into a vein, either as an injection or (following dilution) as an
infusion (drip).
Amikacin can also be given into the peritoneum (abdominal cavity)
during surgery, and can be used to wash out abscess cavities, the
lung cavity and brain cavities.
Your doctor will ensure you are well hydrated before and during

Your doctor will work out the correct dose of amikacin for you and
how often it must be given. This may require blood tests before
The dose will depend upon your age, the infection you have, how
well your kidneys are working, if you have poor hearing and any
other medicines you may be taking.
It will usually be given to you two or three times a day, for up to
10 days.
Adults and children over 12 years: The usual dose is 15 mg per
kg per day which is administered as a single dose or divided into
two equal doses of 7.5 mg per kg administered every 12 hours. The
total dose should not exceed 1.5 g. When treatment is given in to a
vein it is usually administered over a 30 to 60 minute period.
Children up to 12 years: The usual dose is 15 - 20 mg per kg of
body weight once a day or divided into two equal doses of 7.5 mg
per kg which is administered every 12 hours.

Amikacin 250 mg/ml Injection
The following information is intended for medical or healthcare
professionals only
Further to the information included in section 3, practical information on
the preparation/handling of the medicinal product is provided here.

Amikacin is incompatible with some penicillins and cephalosporins,
amphotericin chlorothiazide sodium, erythromycin gluceptate, heparin,
nitrofurantoin sodium, phenytoin sodium, thiopentone sodium and
warfarin sodium, and depending on the composition and strength of
the vehicle, tetracyclines, vitamins of the B group with vitamin C, and
potassium chloride.
At times, amikacin may be indicated as concurrent therapy with other
antibacterial agents in mixed or superinfections. In such instances,
amikacin should not be physically mixed with other antibacterial agents
in syringes, infusion bottles or any other equipment. Each agent should
be administered separately.

Instructions for use and handling
Single use only

Neonates: The initial dose is 10 mg per kg of body weight followed
by 7.5 mg per kg every 12 hours.
Premature infants: The recommended dosing in premature babies
is 7.5 mg per kg every 12 hours.
During treatment you may undergo blood tests and be asked to
provide urine samples. You will possibly also have hearing tests
before and during treatment to look for signs of side effects. Your
doctor may change your dose depending upon the results of these

If you are given too much or too little Amikacin Injection
This medicine will be given to you in a hospital, under the
supervision of a doctor. It is unlikely that you will be given too much or
too little, however, tell your doctor or nurse if you have any concerns.

Like all medicines, amikacin can cause side effects, although not
everybody gets them.
If any of the following happens, tell your doctor immediately
as these are all serious. You may need urgent medical attention or
Rare side-effects which may affect less than 1 person in 1000 are
listed below:
• ringing in your ears or loss of hearing
• decrease in the amount of urine you produce
Not known; numbers of sufferers cannot be estimated from
available data are listed below:
• severe allergic reaction - you may experience a sudden itchy
rash (hives), swelling of the hands, feet, ankles, face, lips, mouth
or throat (which may cause difficulty in swallowing or breathing),
and you may feel you are going to faint
• paralysis
• deafness
• sudden loss of breathing
• severe kidney failure
These are serious side effects. You may need urgent medical

If any of the following happens, tell your doctor as soon as
Uncommon side-effects which may affect more than 1 person in
1000 are listed below:
• skin rash
• nausea and vomiting
• an excessive build up of bacteria or yeast which are resistant to
Rare side-effects which may affect less than 1 person in 1000 are
listed below:
• dizziness or vertigo (spinning sensation)
• headache
• fever
• unusually low amount of red blood cells in the blood (anaemia)
or excessive amounts of the white blood cells known as
eosinophils in the blood (eosinophilia)
• low levels of magnesium in the blood
• abnormal tingling or ‘pins and needles’ sensation
• muscle tremors
• joint pain
• low blood pressure
• itching or hives
Amikacin may lead to changes in your kidney function. Your doctor
may take blood and urine samples to monitor for changes such as
increased levels of creatinine or nitrogen in the blood and protein
or red/white blood cells in urine. Your doctor may also ask you to
undergo hearing tests.
If any of the side effects gets serious, or if you notice any side
effects not listed in this leaflet, please tell your doctor.

Reporting of side effects
If you get any side effects, talk to your doctor, pharmacist or nurse.
This includes any possible side effects not listed in this leaflet.
You can also report side effects directly via:
Yellow Card Scheme
By reporting side effects you can help provide more information on
the safety of this medicine.

Keep out of the reach and sight of children

This medicine must not be used after the expiry date which is
stated on the vial and carton after ‘EXP’. Where only a month and
year is stated, the expiry date refers to the last day of that month.

The vials should be stored at, or below, 25°C.
Unused portions of opened vials must not be stored for later use.
Prepared injections or infusions should be used immediately,
however, if this is not possible they can be stored for up to 24 hours.

What Amikacin Injection contains
The active substance is amikacin. Each millilitre (ml) of solution
contains 250 milligrams (mg) of amikacin (as amikacin sulphate).
The other ingredients are sodium citrate, sodium metabisulphite
and Water for Injections. See section 2 for further information about
sodium metabisulphite.

What Amikacin Injection looks like and contents of the pack
Amikacin Injection is a clear, colourless to pale yellow solution for
injection which comes in glass containers called vials.
It may be supplied in packs containing 5 x 500 mg/2 ml vials

Marketing authorisation holder and manufacturer
Hospira UK Limited, Horizon, Honey Lane, Hurley, Maidenhead,
This leaflet was last revised in 08/2017
Ref: gxAK 1_0

Discard any unused contents
The solution may darken from colourless to a pale yellow but this does
not indicate a loss of potency.
If required, suitable diluents for intravenous use are normal saline or
5% dextrose in water.
Amikacin in concentrations of 0.25% (2.5 mg/ml) may be used
satisfactorily as an irrigating solution in abscess cavities, the pleural
space, the peritoneum and the cerebral ventricles.

In use storage precautions
Following dilution in 0.9% sodium chloride and 5% glucose solutions,
chemical and physical in-use stability has been demonstrated for 24
hours at a temperature not above 25°C.
From a microbiological point of view, the product should be used
immediately. If not used immediately, in-use storage times and
conditions prior to use are the responsibility of the user and would
normally not be longer than 24 hours at 2 to 8°C, unless dilution has
taken place in controlled and validated aseptic conditions.
Ref: gxAK 1_0

04 Aug 2017

+ Expand Transcript

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.